Scarica l'app Stockscreener
1,297.18
0.96%
12.32
Dopo l'orario di chiusura:
1295.13
-2.05
-0.16%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NFLX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1,284.86
Aprire:
$1292
Volume 24 ore:
2.01M
Relative Volume:
0.47
Capitalizzazione di mercato:
$512.23B
Reddito:
$40.17B
Utile/perdita netta:
$9.27B
Rapporto P/E:
61.30
EPS:
21.16
Flusso di cassa netto:
$7.45B
1 W Prestazione:
-0.73%
1M Prestazione:
+6.51%
6M Prestazione:
+47.23%
1 anno Prestazione:
+90.06%
Intervallo 1D:
$1,279.76
$1,302.26
Intervallo di 1 settimana:
$1,271.59
$1,341.15
Portata 52W:
$587.04
$1,341.15
Netflix Inc Stock (NFLX) Company Profile
Nome
Netflix Inc
Settore
Industria
Telefono
408-540-3700
Indirizzo
121 ALBRIGHT WAY, LOS GATOS
Confronta NFLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NFLX
Netflix Inc
|
1,297.18 | 512.23B | 40.17B | 9.27B | 7.45B | 21.16 |
|
DIS
Walt Disney Co
|
124.00 | 213.45B | 94.04B | 8.91B | 10.90B | 4.89 |
|
LYV
Live Nation Entertainment Inc
|
149.27 | 33.31B | 22.74B | 973.97M | 1.34B | 2.93 |
|
WBD
Warner Bros Discovery Inc
|
11.22 | 24.77B | 38.34B | -10.80B | 4.34B | -4.40 |
|
FOXA
Fox Corporation
|
56.25 | 24.61B | 15.18B | 2.19B | 1.84B | 4.67 |
Netflix Inc Stock (NFLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-12 | Reiterato | Oppenheimer | Outperform |
| 2025-06-03 | Reiterato | Jefferies | Buy |
| 2025-05-30 | Reiterato | BofA Securities | Buy |
| 2025-05-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-04-21 | Reiterato | BMO Capital Markets | Outperform |
| 2025-04-21 | Reiterato | Barclays | Equal Weight |
| 2025-04-21 | Reiterato | Canaccord Genuity | Buy |
| 2025-04-21 | Reiterato | Guggenheim | Buy |
| 2025-04-21 | Reiterato | JP Morgan | Overweight |
| 2025-04-21 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2025-04-21 | Reiterato | MoffettNathanson | Buy |
| 2025-04-21 | Reiterato | Morgan Stanley | Overweight |
| 2025-04-21 | Reiterato | Oppenheimer | Outperform |
| 2025-04-21 | Reiterato | Piper Sandler | Overweight |
| 2025-04-21 | Reiterato | Pivotal Research Group | Buy |
| 2025-04-21 | Reiterato | Wells Fargo | Overweight |
| 2025-04-17 | Ripresa | Piper Sandler | Overweight |
| 2025-03-27 | Iniziato | FBN Securities | Outperform |
| 2025-03-17 | Aggiornamento | MoffettNathanson | Neutral → Buy |
| 2025-01-24 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-01-23 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-01-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2025-01-22 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2025-01-22 | Reiterato | Oppenheimer | Outperform |
| 2025-01-22 | Reiterato | Pivotal Research Group | Buy |
| 2025-01-22 | Aggiornamento | Rosenblatt | Neutral → Buy |
| 2025-01-22 | Aggiornamento | The Benchmark Company | Sell → Hold |
| 2025-01-16 | Aggiornamento | Seaport Research Partners | Neutral → Buy |
| 2025-01-15 | Reiterato | BMO Capital Markets | Outperform |
| 2025-01-15 | Reiterato | Oppenheimer | Outperform |
| 2025-01-08 | Reiterato | Goldman | Neutral |
| 2025-01-06 | Reiterato | Argus | Buy |
| 2025-01-03 | Reiterato | The Benchmark Company | Sell |
| 2024-12-19 | Reiterato | UBS | Buy |
| 2024-12-16 | Downgrade | Loop Capital | Buy → Hold |
| 2024-12-16 | Reiterato | Oppenheimer | Outperform |
| 2024-12-11 | Reiterato | JP Morgan | Overweight |
| 2024-11-20 | Reiterato | Pivotal Research Group | Buy |
| 2024-10-18 | Reiterato | Needham | Buy |
| 2024-10-18 | Reiterato | Oppenheimer | Outperform |
| 2024-10-18 | Reiterato | Pivotal Research Group | Buy |
| 2024-10-16 | Reiterato | Loop Capital | Buy |
| 2024-10-11 | Reiterato | Guggenheim | Buy |
| 2024-10-10 | Reiterato | Morgan Stanley | Overweight |
| 2024-10-10 | Reiterato | Oppenheimer | Outperform |
| 2024-10-07 | Downgrade | Barclays | Equal Weight → Underweight |
| 2024-10-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-10-01 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-09-05 | Iniziato | China Renaissance | Hold |
| 2024-08-30 | Reiterato | Pivotal Research Group | Buy |
| 2024-07-17 | Reiterato | Guggenheim | Buy |
| 2024-07-16 | Reiterato | The Benchmark Company | Sell |
| 2024-07-15 | Reiterato | BofA Securities | Buy |
| 2024-07-12 | Reiterato | JP Morgan | Overweight |
| 2024-07-10 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-07-09 | Reiterato | TD Cowen | Buy |
| 2024-07-02 | Reiterato | Argus | Buy |
| 2024-05-28 | Reiterato | Evercore ISI | Outperform |
| 2024-04-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-04-19 | Aggiornamento | Needham | Hold → Buy |
| 2024-04-19 | Reiterato | Pivotal Research Group | Buy |
| 2024-04-15 | Reiterato | Deutsche Bank | Hold |
| 2024-04-12 | Reiterato | Morgan Stanley | Overweight |
| 2024-04-12 | Reiterato | Piper Sandler | Neutral |
| 2024-04-05 | Reiterato | Pivotal Research Group | Buy |
| 2024-03-25 | Reiterato | Citigroup | Neutral |
| 2024-03-12 | Reiterato | Jefferies | Buy |
| 2024-03-11 | Reiterato | Oppenheimer | Outperform |
| 2024-01-30 | Downgrade | Seaport Research Partners | Buy → Neutral |
| 2024-01-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2024-01-24 | Reiterato | BMO Capital Markets | Outperform |
| 2024-01-24 | Reiterato | BofA Securities | Buy |
| 2024-01-24 | Reiterato | Canaccord Genuity | Buy |
| 2024-01-24 | Reiterato | Evercore ISI | Outperform |
| 2024-01-24 | Reiterato | Goldman | Neutral |
| 2024-01-24 | Reiterato | Guggenheim | Buy |
| 2024-01-24 | Reiterato | JP Morgan | Overweight |
| 2024-01-24 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2024-01-24 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2024-01-24 | Reiterato | Morgan Stanley | Overweight |
| 2024-01-24 | Reiterato | Oppenheimer | Outperform |
| 2024-01-24 | Reiterato | Piper Sandler | Neutral |
| 2024-01-24 | Reiterato | Pivotal Research Group | Buy |
| 2024-01-24 | Reiterato | Redburn Atlantic | Buy |
| 2024-01-24 | Reiterato | Robert W. Baird | Outperform |
| 2024-01-24 | Reiterato | TD Cowen | Outperform |
| 2024-01-24 | Reiterato | UBS | Buy |
| 2024-01-24 | Reiterato | Wells Fargo | Overweight |
| 2023-09-18 | Reiterato | Evercore ISI | Outperform |
| 2023-08-25 | Aggiornamento | Loop Capital | Hold → Buy |
| 2023-07-24 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-07-17 | Reiterato | Deutsche Bank | Buy |
| 2023-07-13 | Reiterato | JP Morgan | Overweight |
| 2023-07-12 | Reiterato | UBS | Buy |
| 2023-07-05 | Aggiornamento | Goldman | Sell → Neutral |
| 2023-06-29 | Reiterato | Citigroup | Buy |
| 2023-06-28 | Reiterato | Oppenheimer | Outperform |
| 2023-06-13 | Reiterato | BofA Securities | Buy |
| 2023-06-13 | Reiterato | Guggenheim | Buy |
| 2023-04-19 | Reiterato | Deutsche Bank | Buy |
| 2023-04-19 | Reiterato | JP Morgan | Overweight |
| 2023-04-19 | Reiterato | Jefferies | Buy |
| 2023-04-19 | Reiterato | Piper Sandler | Neutral |
| 2023-04-19 | Reiterato | Pivotal Research Group | Buy |
| 2023-04-19 | Reiterato | Rosenblatt | Neutral |
| 2023-04-19 | Aggiornamento | UBS | Neutral → Buy |
| 2023-04-11 | Ripresa | Robert W. Baird | Neutral |
| 2023-01-23 | Reiterato | Argus | Buy |
| 2023-01-20 | Reiterato | Canaccord Genuity | Buy |
| 2023-01-20 | Reiterato | Deutsche Bank | Buy |
| 2023-01-20 | Reiterato | Evercore ISI | Outperform |
| 2023-01-20 | Reiterato | Goldman | Sell |
| 2023-01-20 | Reiterato | Guggenheim | Buy |
| 2023-01-20 | Reiterato | Jefferies | Buy |
| 2023-01-20 | Reiterato | MoffettNathanson | Market Perform |
| 2023-01-20 | Reiterato | Oppenheimer | Outperform |
| 2023-01-20 | Reiterato | Piper Sandler | Neutral |
| 2023-01-20 | Reiterato | Pivotal Research Group | Buy |
| 2023-01-20 | Reiterato | Robert W. Baird | Neutral |
| 2023-01-20 | Reiterato | The Benchmark Company | Sell |
| 2023-01-20 | Reiterato | Wedbush | Outperform |
| 2023-01-20 | Reiterato | Wolfe Research | Outperform |
| 2023-01-12 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-01-04 | Iniziato | New Street | Neutral |
| 2022-12-29 | Aggiornamento | CFRA | Sell → Buy |
| 2022-12-14 | Reiterato | Jefferies | Hold |
| 2022-12-09 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-06-14 | Downgrade | The Benchmark Company | Hold → Sell |
| 2022-06-10 | Downgrade | Goldman | Neutral → Sell |
| 2022-05-16 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-04-21 | Downgrade | DZ Bank | Buy → Hold |
| 2022-04-21 | Downgrade | Edward Jones | Buy → Hold |
| 2022-04-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-04-20 | Downgrade | BofA Securities | Buy → Underperform |
| 2022-04-20 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-04-20 | Aggiornamento | Needham | Underperform → Hold |
| 2022-04-20 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-04-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Downgrade | Pivotal Research Group | Buy → Sell |
| 2022-04-20 | Downgrade | Stifel | Buy → Hold |
| 2022-04-20 | Downgrade | UBS | Buy → Neutral |
| 2022-04-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-19 | Iniziato | Rosenblatt | Neutral |
| 2022-03-09 | Aggiornamento | Wedbush | Underperform → Neutral |
| 2022-01-31 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-01-24 | Downgrade | Jefferies | Buy → Hold |
| 2022-01-21 | Reiterato | BMO Capital Markets | Outperform |
| 2022-01-21 | Reiterato | BofA Securities | Buy |
| 2022-01-21 | Reiterato | Canaccord Genuity | Buy |
| 2022-01-21 | Reiterato | Cowen | Outperform |
| 2022-01-21 | Reiterato | Deutsche Bank | Hold |
| 2022-01-21 | Reiterato | Goldman | Neutral |
| 2022-01-21 | Reiterato | Guggenheim | Buy |
| 2022-01-21 | Reiterato | JP Morgan | Overweight |
| 2022-01-21 | Reiterato | MoffettNathanson | Neutral |
| 2022-01-21 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| 2022-01-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-21 | Reiterato | Oppenheimer | Outperform |
| 2022-01-21 | Reiterato | Piper Sandler | Overweight |
| 2022-01-21 | Reiterato | Pivotal Research Group | Buy |
| 2022-01-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-01-21 | Reiterato | Stifel | Buy |
| 2022-01-21 | Aggiornamento | The Benchmark Company | Sell → Hold |
| 2022-01-21 | Downgrade | Truist | Buy → Hold |
| 2022-01-21 | Reiterato | UBS | Buy |
| 2022-01-21 | Reiterato | Wolfe Research | Outperform |
| 2021-12-15 | Reiterato | The Benchmark Company | Sell |
| 2021-10-20 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-10-20 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-09-29 | Reiterato | The Benchmark Company | Sell |
| 2021-09-13 | Iniziato | Goldman | Neutral |
| 2021-09-08 | Reiterato | JP Morgan | Overweight |
| 2021-09-07 | Reiterato | Atlantic Equities | Overweight |
| 2021-07-21 | Reiterato | Credit Suisse | Outperform |
| 2021-07-21 | Reiterato | Deutsche Bank | Buy |
| 2021-07-21 | Reiterato | JP Morgan | Overweight |
| 2021-07-21 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2021-07-21 | Reiterato | Stifel | Buy |
| 2021-06-25 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-06-25 | Iniziato | Edward Jones | Hold |
| 2021-05-19 | Ripresa | Jefferies | Buy |
| 2021-04-21 | Ripresa | Oppenheimer | Outperform |
| 2021-04-21 | Reiterato | Pivotal Research Group | Buy |
| 2021-04-21 | Aggiornamento | Stifel | Hold → Buy |
| 2021-04-06 | Ripresa | Evercore ISI | Outperform |
| 2021-04-01 | Iniziato | Piper Sandler | Overweight |
| 2021-03-25 | Reiterato | The Benchmark Company | Sell |
| 2021-03-23 | Aggiornamento | Argus | Hold → Buy |
| 2021-01-21 | Aggiornamento | DZ Bank | Hold → Buy |
| 2021-01-20 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-01-20 | Reiterato | Pivotal Research Group | Buy |
| 2021-01-20 | Reiterato | The Benchmark Company | Sell |
| 2021-01-20 | Aggiornamento | UBS | Neutral → Buy |
| 2021-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-10-21 | Reiterato | BMO Capital Markets | Outperform |
| 2020-10-21 | Reiterato | Bernstein | Outperform |
| 2020-10-21 | Reiterato | Jefferies | Buy |
| 2020-10-21 | Reiterato | Morgan Stanley | Overweight |
| 2020-10-21 | Reiterato | Oppenheimer | Outperform |
| 2020-10-21 | Reiterato | Piper Sandler | Overweight |
| 2020-10-21 | Reiterato | Pivotal Research Group | Buy |
| 2020-10-21 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-10-21 | Reiterato | The Benchmark Company | Sell |
| 2020-10-21 | Reiterato | Wedbush | Underperform |
| 2020-10-21 | Reiterato | Wells Fargo | Equal Weight |
| 2020-10-16 | Reiterato | Morgan Stanley | Overweight |
| 2020-10-15 | Reiterato | Canaccord Genuity | Buy |
| 2020-10-14 | Reiterato | Goldman | Buy |
| 2020-10-07 | Reiterato | Pivotal Research Group | Buy |
| 2020-09-28 | Reiterato | The Benchmark Company | Sell |
| 2020-09-15 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-09 | Ripresa | Raymond James | Mkt Perform |
| 2020-09-04 | Reiterato | The Benchmark Company | Sell |
| 2020-07-29 | Reiterato | Loop Capital | Buy |
Mostra tutto
Netflix Inc Borsa (NFLX) Ultime notizie
Mn Services Vermogensbeheer B.V. Sells 12,400 Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
David J Yvars Group Increases Stock Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Stock Movers: Circle, Marvell, Netflix - Bloomberg.com
Netflix, Inc. (NASDAQ:NFLX) Shares Sold by Trust Point Inc. - MarketBeat
Netflix adds live TV broadcasts and sports in France from TF1 - Los Angeles Times
Sowell Financial Services LLC Sells 1,002 Shares of Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix Dips Its Toe Into Old-Fashioned TV With TF1 Deal - The New York Times
New Season Of Netflix Hit Show ‘Somebody Feed Phil’ Inspires Travel Joy - Forbes
Netflix quietly slides into live TV business via partnership with France's TF1 (NFLX:NASDAQ) - Seeking Alpha
Netflix Stock Analysis: Surging Towards 52-Week Highs, But Is It Overpriced? - Daily Chhattisgarh News
Why the Netflix Stock (NFLX) Rally Isn’t Done Yet - Yahoo Finance
Netflix, Inc. (NFLX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Netflix Crushed Traditional TV. Why the Streamer Now Wants a Piece of the Action. - Barron's
Netflix and France’s TF1 join forces as traditional TV struggles - Euronews.com
State of Alaska Department of Revenue Has $49.63 Million Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix, Inc. (NASDAQ:NFLX) Shares Purchased by LifeWealth Investments LLC - MarketBeat
Netflix Signs Distribution Partnership Deal With France's TF1 - MarketScreener
Roman Butler Fullerton & Co. Trims Stock Holdings in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Kingswood Wealth Advisors LLC Grows Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix (NFLX) Partners with French Network TF1 for Linear TV Content | NFLX Stock News - GuruFocus
Clarius Group LLC Cuts Stock Holdings in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix, Inc. (NASDAQ:NFLX) Shares Bought by Prosperity Wealth Management Inc. - MarketBeat
How Criterion turned its film archives into a streaming powerhouse - Fast Company
Global Trust Asset Management LLC Has $35,000 Stake in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
Netflix Adds Live TV Broadcasts, Sports From France’s TF1 - Bloomberg.com
842 Shares in Netflix, Inc. (NASDAQ:NFLX) Bought by Inscription Capital LLC - MarketBeat
TF1, Netflix Partner To Bring TF1 To Netflix Members In France - marketscreener.com
Netflix And TF1 Group Join Forces To Bring TF1 To Netflix Members In France - About Netflix
Netflix strikes landmark deal with France’s TF1 to show traditional TV - Financial Times
Hoey Investments Inc. Has $223,000 Stock Position in Netflix, Inc. (NASDAQ:NFLX) - MarketBeat
News | Netflix selects Las Vegas Strip as third retail entertainment venue - CoStar
“Netflix House” to open in the fall at King of Prussia mall in Pennsylvania - CBS News
Netflix is letting fans step into their favorite shows with new themed ‘houses’ - San Francisco Chronicle
'My Brilliant Career' Series Adaptation Now in Production in South Australia for Netflix - About Netflix
Netflix Sets Australian Series Adaptation of ‘My Brilliant Career’ - Variety
Netflix House Dallas teases attraction lineup, launch update - Dallas News
Netflix (NFLX) Sees Bearish Option Activity as Shares Inch Highe - GuruFocus
Land of the Lost Reboot in the Works at Netflix - Yahoo
‘Land of the Lost’ Reboot Eyed at Netflix - The Hollywood Reporter
'Netflix House' coming to Dallas and Philly in late 2025; Vegas venue planned for 2027 (NFLX:NASDAQ) - Seeking Alpha
Netflix House to open in Philadelphia and Dallas in late 2025 By Investing.com - Investing.com Nigeria
‘Land Of The Lost’ Series Reboot In Works At Netflix From Legendary Television - Deadline
Joe Forte & Meg LeFauve’s Story House Inks Multi-Year Film Deal With Netflix - Deadline
Streaming surpasses broadcast and cable TV viewing in US for first time - MarketScreener
Netflix is setting its sights on the theme-park world, after already taking over TV - MarketWatch
Netflix Stock Gains 37% YTD, Can the Rally Continue? - MSN
Netflix House offers sneak peek at upcoming attractions in North Texas location - WFAA
Netflix Stock Gains 37% YTD, Can The Rally Continue? - Barchart.com
“Ozark Meets Outer Banks”: ‘The Waterfront’ Is Netflix’s New Crime Drama Series Based on True Events - cosmopolitan.com
YouTube’s Neal Mohan Fires Back at Netflix CEO’s “Killing Time” Dig - Adweek
Netflix Stock (NFLX) Analysis: Price Rebounds Today, Key Levels for Traders - Daily Chhattisgarh News
Netflix Inc Azioni (NFLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Netflix Inc Azioni (NFLX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Masiyiwa Strive | Director |
Jul 01 '25 |
Sale |
1,336.54 |
290 |
387,597 |
0 |
| Neumann Spencer Adam | Chief Financial Officer |
Jul 01 '25 |
Option Exercise |
304.45 |
2,601 |
791,877 |
6,292 |
| Neumann Spencer Adam | Chief Financial Officer |
Jul 01 '25 |
Sale |
1,307.22 |
2,601 |
3,400,075 |
3,691 |
| HASTINGS REED | Director |
Jul 01 '25 |
Sale |
1,329.11 |
9,673 |
12,856,484 |
394 |
| HASTINGS REED | Director |
Jul 01 '25 |
Option Exercise |
107.64 |
26,513 |
2,853,859 |
26,907 |
| HASTINGS REED | Director |
Jul 01 '25 |
Sale |
1,295.78 |
16,840 |
21,821,013 |
10,067 |
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):